Democratic presidential hopeful Pete Buttigieg on Monday released a plan to lower the cost of prescription drugs while also boosting U.S. investment in new drug development and manufacturing.

The wide-sweeping proposal, similar to plans from rival candidates and a bill from House Speaker Nancy Pelosi, calls on the government to negotiate the costs of drugs in Medicare, as well as the government-run “public option” Buttigieg has proposed to compete with private insurers. Those prices would also be available to private health insurance plans and Medicaid. Buttigieg would also cap out-of-pocket spending for seniors and people enrolled in the public option.

Buttigieg aims to boost government investment in drug research and manufacturing, particularly for critical areas like pandemic prevention and antibiotics. His plan would also require more transparency on pricing from the drug industry and companies that administer pharmacy benefits.

“It’s time for a new era of leadership in Washington ready and eager to make drugs affordable and take on pharmaceutical companies,” his plan reads. “Pete has the courage to break with the status quo by focusing on real solutions that will lower costs and make needed — even life-saving — prescription drugs available to all Americans.”